S. Langer, L. Mulam, N. Gupta, and J. Kotwal, “Day 21 serum Free Light Chain (FLC) levels as a predictor of response to therapy in symptomatic multiple myeloma”, CCR, vol. 3, no. 1, pp. 110-118, Sep. 2021.